Evdokia Anagnostou Explained

Evdokia Anagnostou is a professor in the Department of Pediatrics at the University of Toronto, and is cross-appointed as pediatric neurologist and a senior clinician scientist at the Holland Bloorview Kids Rehabilitation Hospital in Toronto, Canada. She is a Tier 2 Canada Research Chair in Translational Therapeutics in Autism Spectrum Disorder.

Career

Anagnostou is currently a professor in the Department of Pediatrics at the University of Toronto, and a senior clinician scientist at the Holland Bloorview Kids Rehabilitation Hospital in Toronto, Canada.[1] [2] Her research focuses on translating findings from basic research studies in the field of Autism Spectrum Disorder and related neurodevelopmental conditions into novel therapeutics. Upon realizing that patients with Autism Spectrum Disorder often have additional disorders (including intellectual disability, ADHD and OCD), Anagnostou and her colleagues launched the Province of Ontario Neurodevelopmental Disorders (POND) Network in 2013 to study multiple neurodevelopmental disorders (including Autism Spectrum Disorder) together.[3] She is a principal investigator at POND, funded by the Ontario Brain Institute.[4] POND co-investigators include Stephen W. Scherer.

Anagnostou was appointed as the inaugural Dr. Stuart D. Sims Chair in Autism at the Holland Bloorview Kids Rehabilitation Hospital in December 2016, and co-leads the Autism Research Centre within the institution.[5] [6] She was also appointed as a Canada Research Chair in Translational Therapeutics in Autism Spectrum Disorder in November 2017.[7] She is an associate editor for Molecular Autism and Autism Research, and a grant reviewer for multiple international agencies

Anagnostou's research has been cited over 23,000 times and has an h-index of 71.[8] She regularly comments on Autism Spectrum Disorder as an expert on various Canadian media platforms.[9] [10] [11] [12] [13]

Selected bibliography

Honours and awards

Notes and References

  1. Web site: Scientists - Bloorview Research Institute. research.hollandbloorview.ca. 2019-02-11.
  2. Web site: Evdokia Anagnostou . ims.utoronto.ca. 2019-02-11.
  3. News: ADHD, OCD, autism: Is it time to redraw the boundaries separating childhood behavioural disorders?. 2019-02-11.
  4. Web site: Province of Ontario Neurodevelopmental Disorders (POND). Children. The Hospital for Sick. sickkids.ca. 2019-02-11.
  5. Web site: Holland Bloorview appoints inaugural autism chair. Shephard. Tamara. 2016-12-15. Toronto.com. 2019-02-11.
  6. Web site: Anagnostou Named Holland Bloorview Inaugural Autism Chair. hollandbloorview.ca. 2019-02-11.
  7. Web site: Canada Research Chairs. Government of Canada. Industry Canada. 2012-11-29. chairs-chaires.gc.ca. 2019-02-11.
  8. Web site: evdokia anagnostou - Google Scholar Citations. 2024-08-01. Google Scholar.
  9. Web site: Treatment to remove metals from children with autism unproven and risky, but no clear regulations . Irel. Nicole . Canadian Broadcasting Corporation. 2019-02-11.
  10. Web site: Study suggests link between DDT exposure and autism risk . www.ctvnews.ca. 16 August 2018 . 2019-02-11.
  11. Web site: The myths and misconceptions of Autism. Breakfast Television Toronto. 2019-02-11.
  12. Web site: Mom with daughter living with autism says there's still a stigma that needs quashing . Canadian Broadcasting Corporation. 2019-02-11. 2017.
  13. Web site: Autism in adults: Why are so few treatments available? . www.ctvnews.ca. 27 April 2016 . 2019-02-11.
  14. Hollander. Eric. Anagnostou. Evdokia. Chaplin. William. Esposito. Katherine. Haznedar. M. Mehmet. Licalzi. Elizabeth. Wasserman. Stacey. Soorya. Latha. Buchsbaum. Monte. 2005-08-01. Striatal Volume on Magnetic Resonance Imaging and Repetitive Behaviors in Autism. Biological Psychiatry. 58. 3. 226–232. 10.1016/j.biopsych.2005.03.040. 15939406. 28829114. 0006-3223.
  15. Hollander. Eric. Bartz. Jennifer. Chaplin. William. Phillips. Ann. Sumner. Jennifer. Soorya. Latha. Anagnostou. Evdokia. Wasserman. Stacey. 2007-02-15. Oxytocin Increases Retention of Social Cognition in Autism. Biological Psychiatry. Advances in Understanding and Treating Autism Spectrum Disorders. 61. 4. 498–503. 10.1016/j.biopsych.2006.05.030. 16904652. 46560. 0006-3223.
  16. Ritz. Louise. Wagner. Ann. Hirtz. Deborah. Sullivan. Lisa. Dukes. Kimberly. Anagnostou. Evdokia. Donnelly. Craig L.. Bregman. Joel D.. Scahill. Lawrence. 2009-06-01. Lack of Efficacy of Citalopram in Children With Autism Spectrum Disorders and High Levels of Repetitive Behavior: Citalopram Ineffective in Children With Autism. Archives of General Psychiatry. 66. 6. 583–590. 10.1001/archgenpsychiatry.2009.30. 19487623. 4112556. 0003-990X.
  17. Hakonarson. Hakon. Schellenberg. Gerard D.. Devlin. Bernie. Buxbaum. Joseph D.. Cook. Edwin H.. Bucan. Maja. Grant. Struan F. A.. Minshew. Nancy J.. Sutcliffe. James S.. May 2009. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature. 459. 7246. 569–573. 10.1038/nature07953. 19404257. 2925224. 1476-4687. 2009Natur.459..569G.
  18. Pinto. Dalila. Delaby. Elsa. Merico. Daniele. Barbosa. Mafalda. Merikangas. Alison. Klei. Lambertus. Thiruvahindrapuram. Bhooma. Xu. Xiao. Ziman. Robert. 2014-05-01. Convergence of Genes and Cellular Pathways Dysregulated in Autism Spectrum Disorders. The American Journal of Human Genetics. 94. 5. 677–694. 10.1016/j.ajhg.2014.03.018. 24768552. 4067558. 0002-9297.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Evdokia Anagnostou".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.